SecBot SecBot
8-K ·Filed Jul 15, 2026

ELV

Elevance Health, Inc.
MIXED
Impact 6/10
Horizondays Processed4mo ago SEC0001156039-26-000058
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The beat and guidance raise are positive catalysts, but underlying weakness in membership and margins suggests caution. Monitor medical cost trends and membership retention in upcoming quarters; the raised cash flow guidance supports capital returns.

DirectionMixed
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$390.33
T+0 close · Jul 15, 2026 · via day close
Latest settled
+2.72%
T+60 · $400.94
Vs SPY
+0.19%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 15 $390.33entry
  2. T+1 · 4mo ago −4.48%α −3.94% · $372.85
  3. T+5 · 4mo ago −0.32%α +0.66% · $389.09
  4. T+20 · 3mo ago +2.26%α −0.09% · $399.14
  5. T+60 · 6w ago +2.72%α +0.19% · $400.94
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Elevance Health reported Q2 2026 adjusted EPS of $7.45, a 20% beat vs consensus of $6.21, and raised full-year adjusted EPS guidance to at least $27.00. Operating revenue grew just 0.8% YoY to $49.8B, while GAAP EPS fell 13.1% and adjusted EPS fell 15.7% YoY, with benefit expense ratio rising 80bp to 89.7% and operating margin compressing to 3.5%. The beat and guidance raise are positive, but declining membership and margin pressure temper the outlook.

Key Financial Metrics

EPS
$7.45
est $6.21 · +20.0%
Revenue
$49.8B
est $48.6B · +2.5% · +0.8% YoY
Rating
beat

Key Facts

  • Q2 2026 adjusted EPS $7.45 vs consensus $6.21 (beat by 20.0%)
  • Q2 2026 operating revenue $49.8B vs consensus $48.63B (beat by 2.4%)
  • FY2026 adjusted EPS guidance raised to at least $27.00 (from at least $26.75)
  • FY2026 GAAP EPS guidance raised to at least $20.10 (from at least $19.85)
  • FY2026 operating cash flow guidance raised to at least $6.0B (from at least $5.5B)
  • Benefit expense ratio 89.7%, up 80bp YoY
  • Health Benefits segment operating gain down 42.6% YoY
  • Medical membership down 1.5% YoY and 1.0% sequentially
  • Repurchased 0.7M shares for $234M in Q2

Financial Impact

Adjusted EPS beat consensus by $1.24 (20%); revenue beat by $1.2B (2.4%). Guidance raise adds ~$0.25 to adjusted EPS floor.

epsrevenueguidanceoperating cash flow

Risk Factors

  • Elevated medical cost trend in Government businesses (Medicare, Medicaid)
  • Membership declines in Medicare Advantage, Medicaid, and Employer Group risk
  • CMS regulatory risk and potential financial exposure from historical risk adjustment data
  • Operating margin compression from targeted investments and higher benefit expense

Market Snapshot

Exchange
NYSE
Sector
Hospital & Medical Service Plans
Analyst Consensus
62% bullish (29 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001156039-26-000058
Document: elv-20260715.htm0001156039-26-000058
Document: 0001156039-26-000058-index-headers.html0001156039-26-000058
Document: 0001156039-26-000058-index.html0001156039-26-000058
Document: 0001156039-26-000058.txt0001156039-26-000058
8-K Data (Synthetic)0001156039-26-000058

Track record

19 reports on ELV

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 10, 20266d ago 8-K Neutral 2/10 Entry $429.48 Now $446.28 +3.91% settles Nov 18
  2. Nov 5, 202611d ago 144 Neutral 2/10 Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
  3. Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
  4. Oct 22, 202625d ago 144 Neutral 2/10 Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
  5. Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
  6. Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
  7. Sep 10, 20269w ago 8-K Neutral 3/10 Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
  8. Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
  9. Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
  10. Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens Wed (10h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 15, 2026